EyePoint (EYPT) stock: insider trades, news & valuation
Health Care · Net sellingShare price and insider trades
EyePoint insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $72K and 3 sold $2.0M of EYPT stock on the open market.
Get emailed when insiders cluster-buy stocks like EYPT
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
EYPT insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | $52K | 1 | — | 0 |
| Q2 2026 | — | 0 | $110K | 3 |
| Q1 2026 | $20K | 1 | $808K | 3 |
| Q4 2025 | — | 0 | $1.1M | 5 |
Valuation, profit and volume
Summary
Over the past 12 months, 2 EyePoint, Inc. insiders reported open-market purchases totaling $72K, while 3 insiders reported sales totaling $2.0M. 10 of 11 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
EYPT stock news and SEC filings
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 18SEC | Karen L. ZaderejDirector | Buy | 10,60049,100 held (+28%) | $4.93 | $52K | -31.0% | — |
| Jul 2SEC | Ramiro RibeiroChief Medical Officer | Sell Plan | 2,438 | $15.02 | $37K | -77.4% | — |
| Jul 2SEC | Ramiro RibeiroChief Medical Officer | Sell Plan | 2,4372,438 held (−50%) | $15.00 | $37K | -77.3% | — |
| Apr 20SEC | Ramiro RibeiroChief Medical Officer | Sell Plan | 2,437 | $15.00 | $37K | -77.3% | — |
| Mar 16SEC | Jay S. DukerCEO, President | Buy | 1,500100,665 held (+2%) | $13.15 | $20K | -74.1% | — |
| Mar 5SEC | Ramiro RibeiroChief Medical Officer | Sell Plan | 2,438 | $17.87 | $44K | -81.0% | — |
| Feb 18SEC | Ramiro RibeiroChief Medical Officer | Sell Plan | 2,437 | $15.00 | $37K | -77.3% | — |
| Jan 7SEC | Ramiro RibeiroChief Medical Officer | Sell Plan | 42,544 | $17.10 | $728K | -80.1% | — |
| Dec 8SEC | Cormorant Asset Management, LpFormer 10% Owner | Sell | 60,0008,265,000 held (−1%) | $15.70 | $942K | -78.3% | — |
| Dec 5SEC | Nancy LurkerDirector | Sell Plan | 9,300206,547 held (−4%) | $15.11 | $141K | -77.5% | — |
| Dec 1SEC | Nancy LurkerDirector | Sell Plan | 500215,847 held (−0%) | $14.95 | $7K | -77.3% | — |
| Dec 1SEC | Nancy LurkerDirector | Sell Plan | 200216,347 held (−0%) | $14.95 | $3K | -77.3% | — |
| Nov 12SEC | Ramiro RibeiroChief Medical Officer | Sell Plan | 2,722 | $11.61 | $32K | -70.7% | — |
Insiders at EyePoint, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Ramiro RibeiroChief Medical Officer | — | $949K | Jul 2, 2026 | — |
| Cormorant Asset Management, LpFormer 10% Owner | — | $942K | Dec 8, 2025 | — |
| Karen L. ZaderejDirector | $52K | — | Aug 18, 2026 | — |
| Nancy LurkerDirector | — | $151K | Dec 5, 2025 | — |
| Jay S. DukerCEO, President | $20K | — | Mar 16, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
EYPT stock: common questions
Are EyePoint, Inc. insiders buying EYPT stock?
In the past 12 months, 2 insiders reported open-market purchases of EYPT worth $72K. The latest was Director Karen L. Zaderej bought $52K of EYPT at $4.93 — first open-market purchase in our records; raises the stake by 28%.
Are EyePoint, Inc. insiders selling EYPT stock?
3 insiders reported sales worth $2.0M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is EYPT's 52-week range?
Over the past year EYPT has traded between $3.15 and $18.85. It last closed at $3.40 on Oct 9, 2026.